In contrast, CCl4-treated mice supplemented with miR-29b showed significant reduced expression of PIK3R1, total AKT3 and p-AKT, which paralleled the improvement in histological severity of liver fibrosis (Figure 3A). This evidence concerns the gene AKT1 and Hepatic fibrosis.